[HTML][HTML] Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI insight, 2020 - ncbi.nlm.nih.gov
Abstract Alpha 1-antitrypsin (AAT) deficiency, a hereditary disorder characterized by low
serum levels of functional AAT, is associated with early development of panacinar …
serum levels of functional AAT, is associated with early development of panacinar …
[HTML][HTML] Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI …, 2020 - Am Soc Clin Investig
JCI Insight - Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human
alpha 1-antitrypsin Go to The Journal of Clinical Investigation About Editors Consulting Editors …
alpha 1-antitrypsin Go to The Journal of Clinical Investigation About Editors Consulting Editors …
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI …, 2020 - pubmed.ncbi.nlm.nih.gov
Alpha 1-antitrypsin (AAT) deficiency, a hereditary disorder characterized by low serum levels
of functional AAT, is associated with early development of panacinar emphysema. AAT …
of functional AAT, is associated with early development of panacinar emphysema. AAT …
[PDF][PDF] Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - insight, 2020 - academia.edu
Alpha 1-antitrypsin (AAT) deficiency is a common autosomal recessive disorder affecting
1/2000 to 1/5000 individuals, about 90,000 people in the United States (1–5). The primary …
1/2000 to 1/5000 individuals, about 90,000 people in the United States (1–5). The primary …
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI Insight, 2020 - europepmc.org
Abstract Alpha 1-antitrypsin (AAT) deficiency, a hereditary disorder characterized by low
serum levels of functional AAT, is associated with early development of panacinar …
serum levels of functional AAT, is associated with early development of panacinar …
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI Insight, 2020 - europepmc.org
Abstract Alpha 1-antitrypsin (AAT) deficiency, a hereditary disorder characterized by low
serum levels of functional AAT, is associated with early development of panacinar …
serum levels of functional AAT, is associated with early development of panacinar …
[HTML][HTML] Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
ML Sosulski, KM Stiles, EZ Frenk, FM Hart… - JCI …, 2020 - Am Soc Clin Investig
JCI Insight - Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human
alpha 1-antitrypsin Go to The Journal of Clinical Investigation About Editors Consulting Editors …
alpha 1-antitrypsin Go to The Journal of Clinical Investigation About Editors Consulting Editors …